Metric Contract Services Strengthens Management Team; Adds New Research and Development Scientists
Sept. 5, 2019, Greenville, N.C. – Metrics Contract Services (Metrics), a division of Mayne Pharma, is pleased to announce Troy Woelfel has joined the company as Vice President of Operations and General Manager of Mayne Pharma Greenville Operations.
In addition, Metrics has added more than 20 analytical chemists and formulation scientists to support the growing pipeline of committed business.
As a member of the senior leadership team, Woelfel will focus on further advancing the performance of the significantly expanded Greenville operations following completion of the $80-million oral solid-dose commercial manufacturing facility in 2018. He has more than 20 years of pharmaceutical industry experience in proprietary and CDMO operations, supply chain, engineering and maintenance.
John Ross, president of Mayne Pharma US said, “Troy has a proven track record of success in improving quality outcomes, building teams and culture, and overseeing significant expansion in complex operating environments. Metrics is seeing a significant increase in new projects and commercial demand, and expansion of the scientific team of formulators and chemists will support this growth. This expansion will enhance the team’s responsiveness, internal analytical capabilities and capacity, and support Metrics’ rigorous scientific approach and specialized knowledge.”
Woelfel has held management positions at Teligent, Pfizer/Hospira and Novo Nordisk. He is a Six Sigma master black belt and a former Naval Flight Officer with multiple deployments throughout the world. Woelfel is a graduate of the United States Naval Academy, where he studied aerospace engineering. He also holds an MBA from the University of North Carolina at Chapel Hill.
About Metrics Contract Services
Metrics Contract Services is a full-service pharmaceutical development and manufacturing organization serving clients worldwide and delivering proven scientific and operational excellence for oral dosage forms.
Metrics’ areas of expertise include quality pharmaceutical formulation development; first-time-in-man formulations; Phase I-III clinical trial materials manufacturing; and analytical method development and validation services leading to commercial scale manufacturing. Technical capabilities include highly potent, cytotoxic and unstable compounds; Schedule II-V controlled substances; and products with poor bioequivalence, for which we offer an impressive proprietary portfolio of advanced delivery methods. Located in Greenville, N.C., Metrics is a proud member of Mayne Pharma. Learn more at www.metricscontractservices.com
About Mayne Pharma
Mayne Pharma is an ASX-listed specialty pharmaceutical company focused on applying its drug delivery expertise to commercialize branded and generic pharmaceuticals. Mayne Pharma also provides contract development and manufacturing services to more than 100 clients worldwide.
Mayne Pharma has a 30-year track record of innovation and success in developing new oral drug delivery systems, and these technologies have been successfully commercialized in numerous products that have been marketed around the world.
Mayne Pharma has two product development and manufacturing facilities based in Greenville, N.C., USA, and Salisbury, Australia, with expertise in formulation of complex oral and topical dose forms including potent compounds, modified-release products and inherently unstable compounds. For further information, visit www.maynepharma.com.